1 results match your criteria: "Division of Gastroenterology and Hepatology hCenter for Cardiovascular Innovation[Affiliation]"
J Cardiovasc Med (Hagerstown)
December 2016
aComprehensive Transplant Center, Northwestern Medicine, Chicago, Illinois, USA bNorthwestern Univeristy Transplant Outcomes Research Collaborative, Northwestern Medicine, Chicago, Illinois, USA cUT Transplant Center, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA dDepartment of Preventive Medicine, Northwestern Medicine, Chicago, Illinois, USA eDepartment of Anesthesia, Northwestern Medicine, Chicago, Illinois, USA fDepartment of Medicine, Division of Cardiology gDepartment of Medicine, Division of Gastroenterology and Hepatology hCenter for Cardiovascular Innovation, Northwestern Medicine, Chicago, Illinois, USA.
Aims: The aim of this study is to assess the impact of obstructive coronary artery disease (CAD) on outcomes after liver transplantation.
Background: Patients considered for liver transplantation are at an increased risk for CAD. Obstructive CAD is a contraindication for liver transplantation at most centres.